Economic impact and clinical profile of the secondary progressive multiple sclerosis (SPMS) patient: the DISCOVER study

被引：0

作者：

Oreja-Guevara, C. ^{[1
]}

Rio, J. ^{[2
]}

Ara Callizo, J. R. ^{[3
]}

Hernandez Perez, M. A. ^{[4
]}

Gracia Gil, J. ^{[5
]}

Alonso Torres, A. M. ^{[6
]}

Pilo de la Fuente, B. ^{[7
]}

Ramio-Torrenta, L. ^{[8
]}

Eichau Madueno, S. ^{[9
]}

Gascon Gimenez, F. ^{[10
]}

Casanova Estruch, B. ^{[11
]}

Martinez Yelamos, S. ^{[12
]}

Aguado Valcarcel, M. ^{[13
]}

Martinez Gines, M. ^{[14
]}

El Berdei Montero, Y. ^{[15
]}

Lopez Real, A. M. ^{[16
]}

Gonzalez Quintanilla, V. ^{[17
]}

Lopez de Silanes, C. ^{[18
]}

Martinez Rodriguez, J. E. ^{[19
]}

Costa-Frossard Franca, L. ^{[20
]}

Garces Redondo, M. ^{[21
]}

Labiano Fontcuberta, A. ^{[22
]}

Castellanos Pinedo, F. ^{[23
]}

Garcia Merino, J. A. ^{[24
]}

Munoz Fernandez, C. ^{[25
]}

Castillo Trivino, T. ^{[26
]}

Meca-Lallana, V. ^{[27
]}

Pena Martinez, J. ^{[28
]}

Rodriguez Antiguedad, A. ^{[29
]}

Prieto Gonzalez, J. M. ^{[30
]}

Aguera Morales, E. ^{[31
]}

Perez Molina, I. ^{[32
]}

Solar Sanchez, M. ^{[33
]}

Herrera Varo, N. ^{[34
]}

Meca-Lallana, J. E. ^{[35
]}

机构：

[1] Hosp Univ Clin San Carlos, Madrid, Spain

[2] Hosp Univ Vall dHebron, CEMCAT, Barcelona, Spain

[3] Hosp Univ Miguel Servet, Zaragoza, Spain

[4] Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain

[5] Complejo Hosp Univ Albacete, Albacete, Spain

[6] Hosp Reg Univ Carlos Haya, Malaga, Spain

[7] Hosp Univ Getafe, Madrid, Spain

[8] Hosp Univ Girona Dr Josep Trueta, Girona, Spain

[9] Hosp Univ Virgen Macarena, Seville, Spain

[10] Hosp Clin Valencia, Valencia, Spain

[11] Hosp Univ & Politecn La Fe, Valencia, Spain

[12] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain

[13] Hosp Alvaro Cunqueiro, Vigo, Spain

[14] Hosp Gregorio Maranon, Madrid, Spain

[15] Hosp Univ Salamanca, Salamanca, Spain

[16] Complexo Hosp Univ A Coruna, La Coruna, Spain

[17] Hosp Univ Marques Valdecilla, Cantabria, Spain

[18] Hosp Univ Torrejon, Madrid, Spain

[19] Hosp del Mar, Barcelona, Spain

[20] Hosp Univ Ramon y Cajal, Madrid, Spain

[21] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain

[22] Hosp Univ 12 Octubre, Madrid, Spain

[23] Hosp Virgen Puerto Plasencia, Caceres, Spain

[24] Hosp Univ Puerta Hierro, Madrid, Spain

[25] Hosp Univ Torrecardenas, Almeria, Spain

[26] Hosp Univ Donostia, San Sebastian, Spain

[27] Hosp Univ La Princesa, Madrid, Spain

[28] Hosp Univ San Agustin, Asturias, Spain

[29] Hosp Univ Cruces, Baracaldo, Spain

[30] Hosp Clin Univ Santiago, Santiago De Compostela, Spain

[31] Hosp Univ Reina Sofia, Cordoba, Spain

[32] Hosp Virgen Salud, Toledo, Spain

[33] Hosp Univ Cabuenes, Gijon, Spain

[34] Hosp Univ Burgos, Burgos, Spain

[35] Hosp Clin Univ Virgen Arrixaca, Neurol Dept, CSUR Multiple Sclerosis & Clin Neuroimmunol Unit, IMIB Arrixaca, Murcia, Spain

来源：

MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P274

引用

页码：306 / 307

页数：2

共 50 条

[41] Clinical and demographic aspects of secondary progressive multiple sclerosis in Argentina
Miguez, Jimena
Serena, Marina Alonso
Pappolla, Agustin
Patrucco, Liliana
Cristiano, Edgardo
Vrech, Carlos
Rojas, Juan, I
Alonso, Ricardo
Cohen, Leila
Garcea, Orlando
Pita, Cecilia
Silva, Berenice A.
Gaitan, Maria, I
Marrodan, Mariano
Negrotto, Laura
Ysrraelit, Maria C.
Luetic, Geraldine
Deri, Norma
Caride, Alejandro
Carnero Contentti, Edgar
Lopez, Pablo A.
Pablo Pettinicchi, Juan
Carra, Adriana
Curbelo, Celeste
Martinez, Alejandra D.
Steinberg, Judith D.
Balbuena, Maria E.
Tkachuk, Veronica
Burgos, Marcos
Knorre, Eduardo
Leguizamon, Felisa
Liwacki, Susana del, V
Piedrabuena, Raul
Barboza, Andres G.
Nofal, Pedro
Volman, Gabriel
Alvez Pinheiro, Amelia
Hryb, Javier
Tavolini, Dario
Blaya, Patricio A.
Silva, Emanuel
Blanche, Jorge
Tizio, Santiago
Caceres, Fernando
Laura Saladino, Maria
Zanga, Gisela
Fracaro, Maria E.
Sgrilli, Gustavo
Pagani Cassara, Fatima
Vazquez, Guido
MEDICINA-BUENOS AIRES, 2020, 80 (06) : 606 - 610
[42] Montreal Cognitive Assessment (MoCA) test in evaluating cognitive dysfunction in patients with Relapsing Remitting Multiple Sclerosis (RRMS) and Secondary Progressive Multiple Sclerosis (SPMS)
Bulbul, N. G.
Demir, S.
Atmaca, M. M.
Togrol, R. E.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 674 - 674
[43] DISCOVER STUDY, FIRST ANALYSIS SPECIFIC FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS BURDEN AND COST IN SPAIN: INTERIM ANALYSIS RESULTS
Oreja-Guevara, C.
Rio Izquierdo, J.
Ara Callizo, J. R.
Hernandez-Perez, M. A.
Gracia Gil, J.
Pilo de la Fuente, B.
Ramio-Torrenta, L.
Alonso Torres, A. M.
Eichau, S.
Martinez Yelamos, S.
Casanova Estruch, B.
Gascon Gimenez, F.
Aguado Valcarcel, M. L.
Martinez Gines, M. L.
Lopez de Silanes, C.
El Berdei Montero, Y.
Lopez Real, A. M.
Martinez Rodriguez, J. E.
Gonzalez Quintanilla, V
Labiano Fontcuberta, A.
Costa-Frossard Franca, L.
Garces Redondo, M.
Garcia Merino, J. A.
Castellanos Pinedo, F.
Meca-Lallana, V
Munoz Fernandez, C.
Castillo Trivino, T.
Rodriguez, A.
Pena Martinez, J.
Prieto Gonzalez, J. M.
Solar Sanchez, D. M.
Aguera Morales, E.
Molina, M., I
Herrera Varo, N.
Aguirre Vazquez, M.
Meca-Lallana, J.
VALUE IN HEALTH, 2020, 23 : S625 - S626
[44] Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study
Tartaglia, Matteo
Canevelli, Marco
Malimpensa, Leonardo
Belvisi, Daniele
Baione, Viola
Ferrazzano, Gina
Leodori, Giorgio
Berardelli, Alfredo
Conte, Antonella
FRONTIERS IN NEUROLOGY, 2023, 14
[45] Sustained disability improvement in patients with secondary progressive multiple sclerosis (SPMS) assessed by a multicomponent endpoint: a post hoc analysis from the ASCEND study
Giovannoni, G.
Steiner, D.
Sellebjerg, F.
Cohan, S.
Jeffery, D.
Rog, D.
Chen, Y.
Dong, Q.
Ho, P. -R.
Cadavid, D.
Amarante, D.
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 671 - 672
[46] Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis
Esposito, Federica
Radaelli, Marta
Martinelli, Vittorio
Sormani, Maria Pia
Boneschi, Filippo Martinelli
Moiola, Lucia
Rocca, Maria Assunta
Rodegher, Mariaemma
Comi, Giancarlo
MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (12) : 1490 - 1499
[47] Siponimod in secondary progressive multiple sclerosis
Rissardo, Jamir Pitton
Caprara, Ana Leticia Fornari
INTERNATIONAL ARCHIVES OF HEALTH SCIENCES, 2020, 7 (03) : 155 - 155
[48] Natalizumab in secondary progressive multiple sclerosis
Edan, Gilles
LANCET NEUROLOGY, 2018, 17 (05): : 384 - 385
[49] Defining secondary progressive multiple sclerosis
Lorscheider, J.
Buzzard, K.
Jokubaitis, V.
Spelman, T.
Havrdova, E.
Horakova, D.
Trojano, M.
Izquierdo, G.
Girard, M.
Duquette, P.
Prat, A.
Lugaresi, A.
Grand'Maison, F.
Grammond, P.
Hupperts, R.
Alroughani, R.
Sola, P.
Boz, C.
Terzi, M.
Pucci, E.
Lechner-Scott, J.
Bergamaschi, R.
Oreja-Guevara, C.
Iuliano, G.
Van Pesch, V.
Bolanos, R. Fernandez
Granella, F.
Rio, M. E.
Ramo, C.
Spitaleri, D. L.
Petersen, T.
Slee, M.
Verheul, F.
Ampapa, R.
Amato, M. P.
McCombe, P.
Vucic, S.
Sanchez Menoyo, J. L.
Cristiano, E.
Barnett, M.
Hodgkinson, S.
Cabrera-Gomez, J. A.
Olascoaga, J.
Saladino, M. L.
Flechter, S.
Gray, O.
Deri, N.
Butzkueven, H.
Kalincik, T.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 798 - 800
[50] Defining secondary progressive multiple sclerosis
Lorscheider, Johannes
Buzzard, Katherine
Jokubaitis, Vilija
Spelman, Tim
Lechner-Scott, Jeannette
McCombe, Pam
Vucic, Steve
Barnett, Michael
Butzkueven, Helmut
Kalincik, Tomas
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (14) : NP15 - NP15

← 1 2 3 4 5 →